Late-Stage Ovarian Cancer With Systemic Multiple Metastases Marked Shrinkage Using a Combination of Wilms' Tumor Antigen 1 (WT1) Dendritic Cell Vaccine, Natural Killer (NK) Cell Therapy, and Nivolumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Late-Stage Ovarian Cancer With Systemic Multiple Metastases Marked Shrinkage Using a Combination of Wilms' Tumor Antigen 1 (WT1) Dendritic Cell Vaccine, Natural Killer (NK) Cell Therapy, and Nivolumab

Published:2024-03-22 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Nagai Hisashi,Karube Ryusuke

Publisher

Springer Science and Business Media LLC

Reference20 articles.

1. Combined cytotoxic chemotherapy and immunotherapy of cancer: modern times;Bailly C;NAR Cancer,2020

2. Combination of chemotherapy and immunotherapy for cancer: a paradigm revisited;Gabrilovich DI;Lancet Oncol,2007

3. The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research;Cheever MA;Clin Cancer Res,2009

4. Role of natural killer cells in control of cancer metastasis;Hanna N;Cancer Metastasis Rev,1982

5. WT1 (Wilms' tumor gene 1): biology and cancer immunotherapy;Sugiyama H;Jpn J Clin Oncol,2010

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined Immune Therapy Proves Effective in an Advanced Hepatocellular Carcinoma Patient With Poor Liver Reserve: A Case Report;Cureus;2024-08-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP